×
For best experience we recommend to activate Javascript in your browser.
Recombinant APP (Crenezumab Biosimilar) antibody
The Humanized Chimeric anti-APP (Crenezumab Biosimilar) antibody (ABIN7597604) specifically detects APP (Crenezumab Biosimilar).
The antibody is reactive with Human samples.
Catalog No. ABIN7597604
$401.14
Plus shipping costs $50.00, if applicable $20.00 dry ice
1 mg ABIN7598385
100 μg ABIN7597604
1 mg ABIN7598385
100 μg ABIN7597604
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant APP (Crenezumab Biosimilar) antibody (ABIN7597604)
Target
APP (Crenezumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Grade
Research Grade
Product Details anti-APP (Crenezumab Biosimilar) Antibody
(hide)
Expression System
Mammalian cells
Purpose
Research Grade Crenezumab Biosimilar Antibody
Specificity
AICD-57, A4, Beta-CTF, Protease nexin-II, Gamma-CTF(50), ABPP, S-APP-beta, APP, Abeta40, Abeta42, AID(59), Amyloid intracellular domain 59, AID(57), S-APP-alpha, Gamma-CTF(59), Beta-secretase C-terminal fragment, Amyloid-beta precursor protein, Amyloid precursor protein, Beta-APP42, PreA4, Alzheimer disease amyloid protein, APPI, PN-II, AICD-59, Alpha-secretase C-terminal fragment, Amyloid-beta A4 protein, Amyloid intracellular domain 57, CVAP, Amyloid intracellular domain 50, Beta-APP40, AD1, Cerebral vascular amyloid peptide, AID(50), Alpha-CTF, Gamma-CTF(57), AICD-50
Purification
Protein A or G purified from cell culture supernatant.
Purity
>95 % by SDS-PAGE.
Isotype
IgG4 kappa
Application Details
(hide)
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.63 mg/mL
Buffer
0.01M PBS, pH 7.4.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Expiry Date
12 months
Target Details for APP (Crenezumab Biosimilar)
(hide)
Target
APP (Crenezumab Biosimilar)
Alternative Name
Crenezumab Biosimilar
Target Type
Biosimilar
Background
AICD-57, A4, Beta-CTF, Protease nexin-II, Gamma-CTF(50), ABPP, S-APP-beta, APP, Abeta40, Abeta42, AID(59), Amyloid intracellular domain 59, AID(57), S-APP-alpha, Gamma-CTF(59), Beta-secretase C-terminal fragment, Amyloid-beta precursor protein, Amyloid precursor protein, Beta-APP42, PreA4, Alzheimer disease amyloid protein, APPI, PN-II, AICD-59, Alpha-secretase C-terminal fragment, Amyloid-beta A4 protein, Amyloid intracellular domain 57, CVAP, Amyloid intracellular domain 50, Beta-APP40, AD1, Cerebral vascular amyloid peptide, AID(50), Alpha-CTF, Gamma-CTF(57), AICD-50
UniProt
P05067
CAS-No
1095207-05-8
Recently viewed
(hide)
You are here:
Homepage
Recombinant anti-APP (Crenezumab Biosimilar) antibody (ABIN7597604)
Chat with us , powered by LiveChat